Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cancer incidence in patients with polyglutamine diseases: a population-based study in Sweden.

The Lancet. Oncology - 1 Jun 2012

Ji Jianguang, Sundquist Kristina, Sundquist Jan

Abstract excerpt

BACKGROUND: Polyglutamine (polyQ) diseases are characterised by the expansion of CAG triplet repeats in specific genes. The accumulated encoded proteins affect the transcription of numerous transcription factors. We investigated whether polyQ diseases reduce the risk of cancer development. METHODS: Data on patients with the polyQ diseases Huntington's disease (HD), spinobulbar muscular atrophy (SBMA), and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Distribution
Share to Databases, Factual
Share to Neurodegenerative Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Peptides

Share to Registries

Share to Sex Distribution

Share to Survival Analysis

Share to Sweden

Source

Identifiers

PMID: 22503213
DOI: 10.1016/S1470-2045(12)70132-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cancer incidence in patients with polyglutamine diseases: a population-based study in Sweden.PMID 22503213Read ↗

Low cancer prevalence in polyglutamine expansion diseases.Semantic proximity Read ↗

Polyglutamine diseases and the risk of cancer.Semantic proximity Read ↗

Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study.Semantic proximity Read ↗

Unbiased human genomic characterization of polyglutamine disorder genes to guide biological understanding and therapeutic strategiesSemantic proximity Read ↗

Juvenile Huntington’s Disease and Other PolyQ Diseases, Update on Neurodevelopmental Character and Comparative Bioinformatic Review of Transcriptomic and Proteomic DataSemantic proximity Read ↗

Juvenile Huntington’s Disease and Other PolyQ diseases, Update on Neurodevelopmental Character and Comparative Bioinformatic Review of Transcriptomic DataSemantic proximity Read ↗

DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases.Semantic proximity Read ↗

CAG-encoded polyglutamine length polymorphism in the human genomeSemantic proximity Read ↗

Polyglutamine (PolyQ) Diseases: Genetics to TreatmentsSemantic proximity Read ↗

Cancer: From Wild-Type to Mutant Huntingtin.Semantic proximity Read ↗

Polyglutamine (polyQ) disordersSemantic proximity Read ↗

Incidence and familial risks in pituitary adenoma and associated tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.